Search
CRISPR Therapeutics AG
CRSPAdd to Watchlist
54.090USD
+1.000+1.88%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
5.19BMarket Cap
LossP/E TTM
CRISPR Therapeutics AG's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of CRISPR Therapeutics AG is 8.31, ranking 149 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -8.77, which is -100.00% below the recent high of 0.00 and -423.85% above the recent low of -45.96.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
